Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors

NCT06302062 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
Tumor Associated Lymph Node T Cell
Immunotherapy

Interventions

DRUG: Tumor Associated Lymph node T cell
DRUG: cyclophosphamide
DRUG: IL-2
DRUG: Serplulimab Injection

Sponsor

Guangzhou FineImmune Biotechnology Co., LTD.